Dyne Therapeutics Inc (DYN)
Healthcare
Biotechnology
25.20 $
-2.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Dyne Therapeutics Inc (DYN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -403 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -62 | 94 | 676 | 585 | -4.2 | -12 | -47 | -120 | -154 | -188 | -292 | -403 | |
| 292 | 614 | 766 | 867 | 0.0 | 0.3 | 0.7 | 1.1 | 1.7 | 1.7 | -1.9 | 2.0 | |
| 19 | 28 | 31 | 44 | 0.0 | 0.0 | 6.6 | 18 | 15 | 20 | 46 | 46 | |
| – | – | – | – | 0.0 | 1.3 | 7.1 | 19 | 18 | – | – | – | |
| 1,029 | -860 | 938 | -1,596 | 0.6 | 1.4 | 5.1 | 9.3 | -5.4 | 26 | -19 | -3.4 | |
| 0.0 | 275 | 326 | 224 | 0.1 | 1.6 | 1.2 | 3.6 | 3.1 | 0.7 | 2.4 | 1.9 | |
| -5,148 | -1,194 | -2,147 | -2,759 | -0.1 | -1.6 | -46 | -138 | 87 | 83 | -204 | -29 | |
| – | 23 | 22 | 22 | – | – | – | – | – | – | – | – | |
| -1,870 | -250 | – | – | 7.4 | 20 | – | – | – | – | – | – | |
| – | – | – | – | -0.1 | -0.1 | -0.1 | 0.0 | – | 0.0 | 0.0 | 148 | |
| 5,210 | -265 | 2,742 | -1,299 | 12 | 20 | 381 | 158 | 37 | 54 | 810 | 890 | |
| -5,148 | -1,365 | 1,271 | -3,473 | 12 | 6.5 | 289 | -100 | -29 | -51 | 313 | 458 | |
| -62 | -181 | 350 | 361 | -4.3 | -13 | -48 | -123 | -157 | -189 | -295 | -405 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.